Indications
Therapeutic Asset Ratings
18,153 results matching 1 filter
91,564
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Etoposide
Radiation Injury
Sun Yat-sen University
P3
BB
(66)
Etoposide
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
University of California, Davis
P3
BB
(66)
Etoposide
Small Cell Carcinoma
SystImmune Inc.
P3
BB
(66)
Everolimus
HER2 Positive Breast Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P3
BB
(66)
Everolimus
Lymphangioleiomyomatosis
University of Cincinnati
P3
BB
(66)
Famitinib
Breast Carcinoma
Fudan University
P3
BB
(66)
FDOPA
Congenital Isolated Hyperinsulinism
University of Alberta
P3
BB
(66)
Fludarabine
Acute Myeloid Leukemia With Multilineage Dysplasia
National Cancer Institute (NCI)
P3
BB
(66)
Fludarabine
Anemia
Masonic Cancer Center, University of Minnesota
P3
BB
(66)
Fludarabine
Lymphoplasmacytic Lymphoma
Affiliated Hospital to Academy of Military Medical Sciences
P3
BB
(66)
Fludarabine
Myeloid Neoplasm
First Affiliated Hospital of Zhejiang University
P3
BB
(66)
Fludarabine
Paroxysmal Nocturnal Hemoglobinuria
Fred Hutchinson Cancer Center
P3
BB
(66)
Fludarabine
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
City of Hope Medical Center
P3
BB
(66)
Fludarabine
Splenic Marginal Zone Lymphoma
UNC Lineberger Comprehensive Cancer Center
P3
BB
(66)
Fludeoxyglucose
Hodgkins Lymphoma
National Cancer Institute (NCI)
P3
BB
(66)
Fluorouracilum
Appendix Carcinoma
City of Hope Medical Center
P3
BB
(66)
Fluorouracilum
Pediatric Hepatocellular Carcinoma
Children's Oncology Group
P3
BB
(66)
Fluorouracilum
Esophageal Squamous Cell Carcinoma
AstraZeneca
P3
BB
(66)
Fluorouracilum
Gastric Adenocarcinoma
Boehringer Ingelheim
P3
BB
(66)
Fluorouracilum
HIV Infectious Disease
National Cancer Institute (NCI)
P3
BB
(66)
Fluorouracilum
Intestinal Neoplasm
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P3
BB
(66)
Fluorouracilum
Neuroendocrine Neoplasm
ITM Solucin GmbH
P3
BB
(66)
Fruquintinib
Non-Small Cell Lung Carcinoma
Immunitas Therapeutics
P3
BB
(66)
Ganaxolone
Tuberous Sclerosis
Marinus Pharmaceuticals
P3
BB
(66)
Gilteritinib
Myelodysplastic Syndrome With Excess Blasts-2
Stichting Hemato-Oncologie voor Volwassenen Nederland
P3
BB
(66)
Showing 2526 to 2550 of 18,153 assets
Previous
Page 102 of 727
Next